COVID-19 treatment is only recommended for those who have a higher risk of progression to severe illness as the benefit will be higher in these individuals. Please check all the risk factors below that apply to you:
High Risk of COVID-19 progression (need 1 to qualify)
- Age > 75 years old
- <1% peripheral B-cells assessed in past 6 months
- Congenital agammaglobulinemia
- Graft versus host disease
- Hematological malignancy on therapy
- HIV infection with CD4 < 200 cells/mm3
- Other severe primary immunodeficiency
- Solid organ transplant
- Solid tumor on immunosuppressive therapy
- Stem cell transplant in the past 2 years
- B-cell depleting agents in the past 12 months (such as rituximab, ocrelizumab)
- CAR-T therapy in past 12 months
- Abatacept
- Tyrosine kinase inhibitors (such as ibrutinib, acalabrutinib)
- High dose corticosteroids (> 20 mg prednisone or equivalent for > 4 weeks)
- Anthracycline derivatives
OR
Factors with increased risk of progression (need 2 to qualify)
- Age 65-74 years old
- Atherosclerotic cardiovascular disease
- Asthma
- Cardiomyopathy
- Cerebral vascular disease
- Chronic liver diseases
- Chronic lung diseases
- Cirrhosis
- Dementia
- Diabetes Mellitus
- Disabilities including Down syndrome
- End stage renal disease
- Heart failure
- HIV infection with CD4 > 200 cells/mm3
- Inflammatory Bowel Disease
- Mental Health Conditions
- Obesity
- Parkinson’s Disease
- Physical Inactivity
- Pregnancy (current or within 6 weeks of pregnancy)
- Smoking history
- Solid tumor (on immunosuppressives > 12 months prior)
- Tuberculosis
- Anti-IL-6, Anti-IL12, Anti-IL-23 treatments
- Corticosteroids 10-20 mg for > 4 weeks




